Simulect

Medicinal product

(Invented) name

Simulect

Active substance (s)

Baziliksimabas

Strength

20 mg

Pharmaceutical form

milteliai ir tirpiklis injekciniam ar infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

L04AC02, Basiliximab

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2013-10-09

Date of renewal

Documents

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

CR-Lygiagretus platinimas

Qualitative and quantitative composition

Powder and solvent for solution for injection or infusion	1 vnt.
Baziliksimabas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
60442	74720	1074720	flakonas	N1+ampulė N1		Receptinis	EU/1/98/084/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2013-10-09	Registruotas